12 Jul 2023 --- Evonik has published preliminary figures for the second quarter. The German specialty chemicals supplier expects adjusted EBITDA of between €430 and 450 million (US$474 and 496 million), a slight improvement compared with the first quarter’s €409 million (US$451 million). However, the company struggled with persistently “very weak” demand across all end markets.The lack of an economic recovery means that earnings fell short of Evonik’s expectations. Compared with the prior-year period, adjusted EBITDA fell by around 40%.
